| EPIC | Company | Index | Dividend Yield | Market Cap | Price Close | % Change |
| AZN |
AstraZeneca
|
FTSE 100
| 2.10 |
£174.42B
| 11,304.00 | 0.50% |
| GSK |
GSK
|
FTSE 100
| 4.14 |
£59.92B
| 1,496.50 | 1.60% |
| HLN |
Haleon
|
FTSE 100
| 2.00 |
£30.4B
| 338.40 | -0.50% |
| SN. |
Smith & Nephew
|
FTSE 100
| 2.03 |
£11.84B
| 1,371.00 | 0.29% |
| CTEC |
ConvaTec Group
|
FTSE 100
| 2.01 |
£4.78B
| 231.80 | -1.70% |
| HIK |
Hikma Pharmaceuticals
|
FTSE 100
| 3.61 |
£3.63B
| 1,615.00 | -1.28% |
| HCM |
Hutchmed China
|
AIM
| |
£2.27B
| 255.00 | 4.80% |
| GNS |
Genus
|
FTSE 250
| 1.27 |
£1.65B
| 2,450.00 | -1.01% |
| INDV |
Indivior
|
FTSE 250
| |
£1.54B
| 1,238.00 | -3.10% |
| UPR |
Uniphar
|
AIM
| 0.01 |
£883.65M
| 340.00 | 0.90% |
| SPI |
Spire Healthcare Group
|
FTSE 250
| 1.06 |
£871.97M
| 247.00 | 14.09% |
| OXB |
Oxford BioMedica
|
FTSE Small Cap
| |
£692.25M
| 592.00 | 2.78% |
| AMS |
Advanced Medical Solutions Group
|
AIM
| 1.23 |
£454.77M
| 212.50 | 3.10% |
| AGY |
Allergy Therapeutics
|
AIM
| |
£395.61M
| 8.30 | -2.50% |
| NIOX |
Niox Group
|
AIM
| 1.70 |
£306.68M
| 73.60 | |
| PRTC |
Puretech Health
|
FTSE Small Cap
| |
£257.15M
| 120.20 | 12.97% |
| FARN |
Faron Pharmaceuticals OY
|
AIM
| |
£209.91M
| 185.10 | 1.10% |
| AVCT |
Avacta Group
|
AIM
| |
£208.92M
| 52.25 | -7.00% |
| TSTL |
Tristel
|
AIM
| 3.65 |
£176.57M
| 361.50 | 1.60% |
| ANCR |
Animalcare Group
|
AIM
| 2.00 |
£172.47M
| 250.00 | -2.60% |
| MXCT |
Maxcyte Inc
|
AIM
| |
£161.75M
| 147.69 | -1.20% |
| BMK |
Benchmark Holdings
|
AIM
| |
£135.69M
| 22.05 | 1.50% |
| EKF |
EKF Diagnostics Holdings
|
AIM
| |
£134.73M
| 30.00 | 1.00% |
| 4BB |
4basebio
|
AIM
| |
£128.85M
| 800.00 | -0.40% |
| BVXP |
Bioventix
|
AIM
| 6.35 |
£127.49M
| 2,426.00 | -2.20% |
| DXRX |
Diaceutics
|
AIM
| |
£124.38M
| 149.05 | -0.50% |
| SCLP |
Scancell Holdings
|
AIM
| |
£105.33M
| 10.03 | -1.10% |
| SDI |
SDI Group
|
AIM
| |
£101.94M
| 96.50 | -1.50% |
| ANP |
Anpario
|
Main Market
| 2.32 |
£99.89M
| 484.00 | -0.90% |
| STX |
Shield Therapeutics
|
AIM
| |
£84.4M
| 8.00 | -7.90% |
| OBI |
Ondine Biomedical Inc
|
AIM
| |
£68.86M
| 15.00 | 2.60% |
| HVO |
Hvivo
|
AIM
| 2.05 |
£66.34M
| 9.88 | -5.10% |
| ANIC |
Agronomics
|
AIM
| |
£64.8M
| 6.70 | -0.60% |
| IMM |
ImmuPharma
|
AIM
| |
£61.08M
| 12.50 | -3.00% |
| EAH |
Eco Animal Health Group
|
AIM
| |
£58.27M
| 87.21 | -4.30% |
| CREO |
Creo Medical Group
|
AIM
| |
£48.8M
| 12.13 | -0.80% |
| SBTX |
SkinBioTherapeutics
|
AIM
| |
£43.02M
| 16.60 | -14.90% |
| SPEC |
Inspecs Group
|
AIM
| |
£40.67M
| 40.50 | -0.30% |
| KMK |
Kromek Group
|
AIM
| |
£39.3M
| 6.09 | 8.70% |
| SAR |
Sareum Holdings
|
AIM
| |
£37.27M
| 26.58 | -5.60% |
| OHGR |
One Health Group
|
AIM
| 0.02 |
£33.73M
| 246.00 | |
| NCYT |
Novacyt SA
|
AIM
| |
£27.69M
| 40.50 | 4.20% |
| POLB |
Poolbeg Pharma
|
AIM
| |
£27.54M
| 3.93 | -2.10% |
| AREC |
Arecor Therapeutics
|
AIM
| |
£27.37M
| 71.50 | -1.30% |
| FUM |
Futura Medical
|
AIM
| |
£26.85M
| 5.76 | 14.60% |
| ABDX |
Abingdon Health
|
AIM
| |
£21.8M
| 5.89 | 2.60% |
| IHC |
Inspiration Healthcare Group
|
AIM
| |
£19.28M
| 21.85 | 0.60% |
| FAB |
Fusion Antibodies
|
AIM
| |
£18.47M
| 16.75 | 25.90% |
| TRX |
Tissue Regenix Group
|
AIM
| |
£16.74M
| 23.12 | -1.50% |
| COG |
Cambridge Cognition Holdings
|
AIM
| |
£15.91M
| 37.58 | -0.40% |
| EDEN |
Eden Research
|
AIM
| |
£14.93M
| 2.57 | -2.40% |
| AGL |
Angle
|
AIM
| |
£11.41M
| 3.30 | -0.70% |
| IXI |
Ixico
|
AIM
| |
£10.66M
| 11.50 | -1.50% |
| OPTI |
OptiBiotix Health
|
AIM
| |
£10.33M
| 9.80 | -3.30% |
| VRCI |
Verici Dx
|
AIM
| |
£10.22M
| 0.71 | -4.80% |
| GENI |
Genincode
|
AIM
| |
£9.61M
| 3.99 | 1.40% |
| OBD |
Oxford BioDynamics
|
AIM
| |
£9.4M
| 0.47 | -4.00% |
| CEL |
Celadon Pharmaceuticals
|
AIM
| |
£9.23M
| 13.40 | |
| PRM |
Proteome Sciences
|
AIM
| |
£8.86M
| 3.00 | 8.00% |
| POLX |
Polarean Imaging
|
AIM
| |
£7.85M
| 0.65 | -3.20% |
| RUA |
RUA Life Sciences
|
AIM
| |
£6.98M
| 11.10 | -6.90% |
| SUN |
Surgical Innovations Group
|
AIM
| |
£6.53M
| 0.66 | -2.30% |
| MHC |
MyHealthChecked
|
AIM
| |
£5.46M
| 10.99 | 5.30% |
| GDR |
Genedrive
|
AIM
| |
£3.12M
| 0.55 | -1.60% |
| BELL |
Belluscura
|
AIM
| |
£3.01M
| 0.75 | -1.10% |
| VAL |
ValiRx
|
AIM
| |
£2.53M
| 0.62 | -2.20% |
| GUN |
Gunsynd
|
AIM
| |
£1.93M
| 0.13 | 9.50% |
| PYC |
Physiomics
|
AIM
| |
£1.59M
| 0.51 | -3.80% |
| TLY |
Totally
|
AIM
| |
–
| 0.24 | -1.90% |
| TRLS |
Trellus Health
|
AIM
| |
–
| 0.60 | 7.30% |